TITLE

Efficacy of β-adrenergic blocker plus 5-isosorbide mononitrate and endoscopic band ligation for prophylaxis of esophageal variceal rebleeding: A meta-analysis

AUTHOR(S)
Shi-Hua Ding; Jun Liu; Jian-Ping Wang; Ozdogan, Osman C.
PUB. DATE
May 2009
SOURCE
World Journal of Gastroenterology;5/7/2009, Vol. 15 Issue 17, p2151
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
AIM: To systematically assess the efficacy and safety of β-adrenergic blocker plus 5-isosorbide mononitrate (BB + ISMN) and endoscopic band ligation (EBL) on prophylaxis of esophageal variceal rebleeding. METHODS: Randomized controlled trials (RCTs) comparing the efficacy and safety of BB + ISMN and EBL on prophylaxis of esophageal variceal rebleeding were gathered from Medline, Embase, Cochrane Controlled Trial Registry and China Biological Medicine database between January 1980 and August 2007. Data from five trials were extracted and pooled. The analyses of the available data using the Revman 4.2 software were based on the intention-to-treat principle. RESULTS: Four RCTs met the inclusion criteria. In comparison with BB + ISMN with EBL in prophylaxis of esophageal variceal rebleeding, there was no significant difference in the rate of rebleeding [relative risk (RR), 0.79; 95% CI: 0.62-1.00; P = 0.05], bleeding-related mortality (RR, 0.76; 95% CI: 0.31-1.42; P = 0.40), overall mortality (RR, 0.81; 95% CI: 0.61-1.08; P = 0.15) and complications (RR, 1.26; 95% CI: 0.93-1.70; P = 0.13). CONCLUSION: In the prevention of esophageal variceal rebleeding, BB + ISMN are as effective as EBL. There are few complications with the two treatment modalities. Both BB + ISMN and EBL would be considered as the first-line therapy in the prevention of esophageal variceal rebleeding.
ACCESSION #
42834339

 

Related Articles

  • Hemodynamic Assessment of Pharmacological Response in the Treatment of Portal Hypertension: A Need to Know. Grace, Norman D. // American Journal of Gastroenterology;Aug2000, Vol. 95 Issue 8, p1862 

    Offers observation on a meta-analysis of seven published randomized controlled trials comparing a nonselective β-adrenergic blocker to a placebo or no treatment for the prevention of initial variceal hemorrhage. Risk of hemorrhage from varices in patients with cirrhosis and large esophageal...

  • Benefit of combination β-blocker and endoscopic treatment to prevent variceal rebleeding: A meta-analysis. Funakoshi, Natalie; Ségalas-Largey, Frédérique; Duny, Yohan; Oberti, Frédéric; Valats, Jean-Christophe; Bismuth, Michael; Daurès, Jean-Pierre; Blanc, Pierre // Annals of Gastroenterology & Hepatology;2011, Vol. 9 Issue 96, p5982 

    AIM: To determine whether the association of β-blockers with endoscopic treatment is superior to endoscopic treatment alone for the secondary prophylaxis of oesophageal variceal bleeding. METHODS: Randomised controlled trials comparing sclerotherapy (SCL) with SCL plus β-blockers (BB) or...

  • Propranolol in Primary and Secondary Prophylaxis of Variceal Bleeding Among Cirrhotics in India: A Hemodynamic Evaluation. De, Binay K.; Sen, Sambit; Biswas, Pranab K.; Sengupta, Debapriya; Biswas, Jayanta; Santra, Amal; Hazra, Baburam; Maity, Ajit K. // American Journal of Gastroenterology;Aug2000, Vol. 95 Issue 8, p2023 

    OBJECTIVE: In the present study, we attempted to complete the hemodynamic assessment of propranolol response in cirrhotics with esophageal varices at high risk of bleeding, in one sitting, so as to identify nonresponders at the earliest. Some noninvasive indicators of this response were also...

  • Benefit of combination β-blocker and endoscopic treatment to prevent variceal rebleeding: A meta-analysis. Funakoshi, Natalie; Ségalas-Largey, Frédérique; Duny, Yohan; Oberti, Frédéric; Valats, Jean-Christophe; Bismuth, Michael; Daurès, Jean-Pierre; Blanc, Pierre // Annals of Gastroenterology & Hepatology;2011, Vol. 9 Issue 94, p5982 

    AIM: To determine whether the association of β-blockers with endoscopic treatment is superior to endoscopic treatment alone for the secondary prophylaxis of oesophageal variceal bleeding. METHODS: Randomised controlled trials comparing sclerotherapy (SCL) with SCL plus β-blockers (BB) or...

  • Pro: Cirrhotic Patients With Small Esophageal Varices Should Undergo Primary Prophylaxis. Giannini, Edoardo G. // American Journal of Gastroenterology;Sep2009, Vol. 104 Issue 9, p2132 

    The article focuses on the issue concerning the risk of prophylactic intervention to patients suffering from liver cirrhosis with small esophageal varices. It cites that primary prophylaxis with beta-blockers is ideal in preventing high risk of bleeding in patients with small varices. It also...

  • PREVENTION OF RECURRENT VARICEAL HEMORRHAGE: TO BLOCK OR NOT TO BLOCK? Avezzano, Eric S.; Seefe, Leonard B.; Johnson, David A.; Cattau, Edward // American Journal of Gastroenterology;May1990, Vol. 85 Issue 5, p614 

    Comments on a study about the effect of β-blockade on recurrent gastrointestinal bleeding in patients with alcoholic cirrhosis. Three forms of management of esophageal varices; Effectiveness of propanolol compared to atenol in preventing rebleeding; Failure to demonstrate a significant...

  • Adherence and adequacy of therapy for esophageal varices prophylaxis. Maddur, Haripriya; Naik, Suraj; Siddiqui, Ali; Rockey, Don; Siddiqui, Ali A; Rockey, Don C // Digestive Diseases & Sciences;Nov2011, Vol. 56 Issue 11, p3129 

    Aims: Esophageal varices (EVs) are prevalent among cirrhotics and their bleeding leads to substantial morbidity and mortality. Management guidelines available during this study recommended beta-blocker therapy for primary prophylaxis and beta-blocker or band ligation (EVL) for...

  • Beta-Blockers to Prevent Gastroesophageal Varices in Patients with Cirrhosis. Groszmann, Roberto J.; Garcia-Tsao, Guadalupe; Bosch, Jaime; Grace, Norman D.; Burroughs, Andrew K.; Planas, Ramon; Escorsell, Angels; Garcia-Pagan, Juan Carlos; Patch, David; Matloff, Daniel S.; Gao, Hong; Makuch, Robert // New England Journal of Medicine;11/24/2005, Vol. 353 Issue 21, p2254 

    Background: Nonselective beta-adrenergic blockers decrease portal pressure and prevent variceal hemorrhage. Their effectiveness in preventing varices is unknown. Methods: We randomly assigned 213 patients with cirrhosis and portal hypertension (minimal hepatic venous pressure gradient [HVPG] of...

  • VARICEAL BLEEDING AND βBLOCKADE: PERMUTATION ON THE THEME? Pfeffer, Robert; Reinus, John F.; Cattau Jr., Edward L.; Johnson, David A. // American Journal of Gastroenterology;Dec1990, Vol. 85 Issue 12, p1651 

    Comments on a study which focused on the ability of propranolol to prevent the recurrence of esophageal varices after obliteration by endoscopic sclerotherapy. Opinion on the theory on the effects of reduction in variceal blood flow and intraluminal pressure caused by propranolol; Effect of the...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics